Σύγκριση μεθόδων

	ALSFRS-R	Πολλαπλή Σκλήρυνση Ποιότητα Ζωής-54 (MSQOL-54)
Πεδίο	Νευρολογία	Νευρολογία
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1999	1995
Δημιουργός	James M. Cedarbaum, NIH/NINDS	Barbara G. Vickrey, UCLA
Τύπος	Clinician-rated and patient-reported hybrid	Self-report questionnaire
Θεμελιώδης πηγή	Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999). The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. Journal of the Neurological Sciences, 169(1-2), 13-21.	Vickrey, B. G., Hays, R. D., Genovese, B. J., Myers, L. W., & Ellison, G. W. (1995). Outcomes in Multiple Sclerosis: The Multiple Sclerosis Quality of Life-54 Scale. Health Psychology, 14(1), 34-42.
Εναλλακτικές ονομασίες	ALS FRS-R, Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised	MS QoL-54
Συναφείς	4	4
Σύνοψη	The ALSFRS-R is a 12-item clinician-administered functional rating scale designed to assess disease progression and functional status in amyotrophic lateral sclerosis (ALS). Introduced by Cedarbaum and colleagues in 1999, it expands upon the original ALSFRS by incorporating respiratory function assessment. It is the primary outcome measure in ALS clinical trials and routine clinical monitoring, providing quantitative tracking of disease decline that predicts survival and guides management decisions.	The MSQOL-54 is a disease-specific quality-of-life instrument designed to assess the physical and mental burden of multiple sclerosis on patients' daily functioning and well-being. Developed by Vickrey and colleagues in 1995, it combines the widely-used SF-36 generic health questionnaire with 18 MS-specific items to provide comprehensive measurement of QoL in MS populations. This scale is a cornerstone tool in MS clinical research and patient monitoring.